Previous studies have indicated that adiponectin (APN) protects against cardiac remodeling, but the underlying mechanism remains unclear. The present study aimed to elucidate how APN regulates inflammatory responses and cardiac fibrosis in response to angiotensin II (Ang II). Male APN knockout (APN KO) mice and wild-type (WT) C57BL/6 littermates were sc infused with Ang II at 750 ng/kg per minute. Seven days after Ang II infusion, both APN KO and WT mice developed equally high blood pressure levels. However, APN KO mice developed more severe cardiac fibrosis and inflammation compared with WT mice. This finding was demonstrated by the up-regulation of collagen I, ␣-smooth muscle actin, IL-1␤, and TNF-␣ and increased macrophage infiltration in APN KO mice. Moreover, there were substantially fewer microtubule-associated protein 1 light chain 3-positive autophagosomes in macrophages in the hearts of Ang II-infused APN KO mice. Additional in vitro studies also revealed that globular APN treatment induced autophagy, inhibited Ang II-induced nuclear factor-B activity, and enhanced the expression of antiinflammatory cytokines, including IL-10, macrophage galactose N-acetyl-galactosamine specific lectin 2, found in inflammatory zone 1, and type-1 arginase in macrophages. In contrast, APN-induced autophagy and antiinflammatory cytokine expression was diminished in Atg5-knockdown macrophages or by Compound C, an inhibitor of adenosine 5Ј-monophosphate-activated protein kinase. Our study indicates that APN activates macrophage autophagy through the adenosine 5Ј-monophosphateactivated protein kinase pathway and suppresses Ang II-induced inflammatory responses, thereby reducing the extent of cardiac fibrosis. (Endocrinology 155: 2254 -2265, 2014) 
H
ypertensive cardiac remodeling is characterized by ventricular hypertrophy and interstitial fibrosis, which are the main causes of heart failure. Emerging evidence suggests that activation of renin-angiotensin II (Ang II) system is a primary cause of cardiac fibrosis in hypertensive heart disease (1, 2), but the underlying mechanism remains unclear. Recent studies demonstrate that inflammation plays a fundamental role in cardiovascular diseases, such as atherosclerosis, hypertension, and infarction (2) . Infiltration of inflammatory cells in the heart is an early event in Ang II-induced hypertensive cardiac remodeling. The inflammatory components of this process include macrophages, T cells, and mast cells, which are associated with cytokine secretion, extracellular matrix deposition, and cardiac fibrosis development (3) (4) (5) (6) (7) (8) . However, the precise inflammatory mechanism and macrophage functions in Ang II-induced cardiac fibrosis remain to be revealed.
Recent studies have reported that adipose tissues can secrete numerous cytokines, known as adipokines. Adiponectin (APN) (also referred to as adipocyte complement-related protein (30 kDa) , adiponectin C1Q and collagen domain containing and gelatin-binding protein-28) is a 30-kDa adipokine secreted primarily by adipocytes. Total plasma APN levels typically range from 3 to 30 g/mL in normal human subjects (9) . However, the levels of APN are significantly reduced in various diseases, including obesity, type 2 diabetes, hypertension, acute myocardial infarction (MI), and heart failure (9) . Although most adipokines induce inflammation, APN exerts antiinflammatory functions and protects against a variety of cardiovascular diseases, such as atherosclerosis, diabetes, vascular remodeling, hypertrophic cardiomyopathy, and myocardial ischemia-reperfusion injury (9) . For example, treatment with recombinant APN inhibits reactive oxygen species (ROS)-induced cardiomyocyte remodeling by activating AMP-activated protein kinase (AMPK) and inhibiting ERK signaling and nuclear factor-B (NF-B) activity (10) . APN also protects against Ang II-induced cardiac fibrosis through the AMPK-dependent peroxisome proliferator-activatived receptors-␣ pathway (11) . However, the mechanism by which APN regulates inflammatory responses and macrophages function, leading to Ang II-induced cardiac fibrosis, remains unclear.
Autophagy is a major intracellular degradation process that delivers cytoplasmic constituents to the vacuole/lysosome and plays essential roles in cell survival or death depending on the cellular context (12) . Normally, autophagy occurs at a basal rate in most cells and is critical for maintenance of cellular homeostasis. However, under physiological stress, such as starvation or growth factor withdrawal, autophagic activity is up-regulated (13) . Increasing evidence has shown that autophagic dysfunction is the main reason for numerous pathological states, including aging, neurodegenerative diseases, immune disorders, and cancer (13, 14) . Interestingly, activation of autophagy has also been observed in cardiac hypertrophy, ischemia-reperfusion injury, and advanced atherosclerotic plaques (12, 13, 15) . In addition, autophagy play an important role in the innate and adaptive immune defense programs, leading to increased expression of inflammatory cytokines, such as TNF-␣ and interferon-␥ (16, 17) . A recent study demonstrated that autophagy is stimulated by an essential mediator of APN action, AMPK (18) . However, the effect of APN on autophagy in macrophages during Ang II-induced cardiac inflammation and fibrosis remains unknown.
In the present study, we investigated the role of APN in Ang II-induced cardiac inflammation and fibrosis and the molecular mechanism involved in the regulation of autophagy by APN. Our results indicated that APN deficiency increased cardiac fibrosis, macrophage infiltration, and inflammatory cytokine expression (TNF-␣ and IL-1␤) in heart tissue. This was associated with decreased autophagy in heart macrophages. These results suggest that APN-mediated increases in macrophage autophagy contribute to the inhibition of cardiac inflammation and fibrosis.
Materials and Methods

Antibodies and reagents
Anti-Mac-2 (macrophage galactose-specific lectin-2), anti-IL-1␤, anti-TNF-␣, and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were from Santa Cruz Biotechnology, Inc. Anticollagen anti-F4/80, anti-␣-smooth muscle actin (␣-SMA) were obtained from Abcam. Anti-LC3(microtubule-associated protein 1 light chain 3) was from MBL International Operation. Anti-phosphor-AMPK and anti-AMPK were from Cell Signaling Technology. Fluorescein isothiocyanate or tetramethylrhodamine-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. Recombinant globular APN was purchased from BioVision, Inc. Compound C was from Calbiochem. Ang II and other reagents were from Sigma-Aldrich.
Animal model
APN knockout (APN KO) mice, Atg5
ϩ/Ϫ mice, and wild-type (WT) C57/BL6 mice (both male and aged 10 -12 wk) were purchased from The Jackson Laboratory. Mice were randomly divided into 4 groups for treatment (n ϭ 6 -8 per group): WTϩsaline, KOϩsaline, WTϩAng II, and KOϩAng II. The osmotic minipump (ALZET Model 1007D; DURECT) filled with Ang II or acetic acid saline (vehicle) was placed sc in the intrascapular area to deliver Ang II at an infusion rate of 750 ng/kg per minute for 7 days as described previously (7, 19) . All procedures were performed according to experimental protocols approved by the Capital Medical University Institutional Committee for Use and Care of Laboratory Animals.
Blood pressure (BP) measurement and cardiac echocardiography
Systolic BP (SBP) and heart rate were measured at the indicated day using a computerized mouse tail cuff system (BP-98A; Softron) as we described elsewhere (20, 21) . Cardiac echocardiography was performed using Vevo 2000 high-resolution micro imaging system (Visual Sonic) after anesthetized with isoflurane as we previously described (22, 23) .
Histological and immunohistochemical analysis
After 7 days of saline or Ang II infusion, heart tissues were harvested, fixed in 10% formalin, and sectioned at 5-m thickness. Hematoxylin/eosin (H&E) and Masson's trichrome staining were performed using standard procedures (7, 19) . Cardiac fibrosis were calculated based upon percentages of collagenstained areas in the total myocardial area (7). Immunohistochemistry was performed as we described (7, 19) . The primary antibodies were used: anti-Mac-2 (1:400), anti-IL-1␤ ( Frozen heart sections (8 m) or cells were stained with primary antibodies, including rabbit anti-LC3 (1:400) and rat anti-F4/80 (1:100), at 4°C overnight and then incubated with fluorescein isothiocyanate or tetramethylrhodamine-conjugated secondary antibodies at room temperature for 1 hour. Dying macrophages were detected by costaining of F4/80 and transferase-mediated dUTP nick-end labeling (TUNEL) with the In Situ Cell Death Detection kit (Promega) according to the manufacturer's instructions. Images were viewed and captured using a deconvolution microscope with a Zeiss Plan Apochromat 630ϫ, 1.4 N.A. objective lens. We randomly counted 100 macrophages of every sample to calculate the total number of autophagosomes and then made statistical analysis. MitoTracker and DCF (Molecular Probes) were used to examine generation of mitochondrial ROS (24, 25) .
RNA extraction and real-time PCR analysis
Total RNA was isolated by TRI reagent (Invitrogen), and realtime PCR was performed as described (20, 21) . Primers used in the research were for collagen I, 5Ј-GAGCGGAGAGTACTG-GATCG-3Ј and 5Ј-TACTCGAACGGGAATCCATC-3Ј; ␣-SMA, 5Ј-GCAAACAGGAATACGACGAAGC-3Ј and 5Ј-GCTTTGG-GCAGGAATGATTTG-3Ј; IL-1␤, 5Ј-CTTCAGGCAGGCAG-TATCACTCAT-3Ј and 5Ј-TCTAATGGGAACGTCACACAC-CAG-3Ј; TNF-␣, 5Ј-CATGAGCACAGAAAGCATGATCCG-3Ј and 5Ј-AAGCAGGAATGAGAAGAGGCTGAG-3Ј; IL-10, 5Ј-GCTATGCTGCCTGCTCTTACTGA-3Ј and 5Ј-TCATGGCCT-TGTAGACACCTTGG-3Ј; type-1 arginase (Arg-1), 5Ј-AGTCCT-TAGAGATTATCGGAGCG-3Ј and 5Ј-GGACACAGGTTGCC-CATGCAGAT-3Ј; found in inflammatory zone 1 (Fizz1), 5Ј-AAT-GAGGGCTGGTGAGATGA-3Ј and 5Ј-GGACTCTCTCCTTC-CACCAT-3Ј; macrophage galactose N-acetyl-galactosamine specific lectin 2 (Mgl-2), 5Ј-CCTGTGGCGCATCCTCT-3Ј and 5Ј-GGGAATTTTGGGATCCAAT-3Ј; and GAPDH, 5Ј-CCTGG-AGAAACCTGCCAAGTATGA-3Ј and 5Ј-TTGAAGTCACAG-GAGACAACCTGG-3Ј. Real-time PCR was performed with use of Bio-Rad iQ5.
Enzyme-linked immunosorbent assay
The protein level of IL-1␤ and TNF-␣ in heart were measured by using a commercial ELISA kit (Xinbosheng) according to the manufacturer's instructions.
Fluorescence-activated cell sorter analysis
The infiltrated inflammatory cells were quantified by flow cytometry as we described before (20, 21, 26) . In Brief, hearts were perfused with cold PBS, then minced and digested with 0.1% collagenase II and 2.4-U/mL dispase II in PBS at 37°C for 15 minutes. Cell suspensions were then centrifuged and stained with a combination of fluorochrome-coupled antibodies to CD45, F4/80, and CD206 (BD Biosciences) for 30 minutes in the dark. Data were collected and analyzed by using an EPICS XL Flow Cytometer (Beckman Coulter) and CellQuest (Beckman), respectively.
Cell culture and treatment
Bone marrow-derived macrophages (BMDMs) were isolated from tibias and femurs of 3-month-old WT, APN knockout (APN KO), and Atg5 ϩ/Ϫ mice as previously described (27) . The adherent BMDMs were pretreated with globular domain of APN (10 g/mL) for 30 minutes and then incubated with Ang II (100nM) or vehicle for 48 hours. In some experiments, the BMDMs were incubated with Compound C (10M) to block AMPK pathway before the APN treatment.
Electron microscopy (EM)
EM was performed as reported previously (28) . Briefly, cells were fixed with 2.5% (wt/vol) glutaraldehyde phosphate buffered 2.5% glutaraldehyde (pH 7.4), postfixed for 2 hours with 1% osmium tetroxide, dehydrated through a graded ethanol series, and embedded in Epon medium (Polysciences). Ultrathin 60-nm sections were stained with 2% uranyl acetate for 15 minutes, followed by 1% lead citrate for 10 minutes. Cells were examined using a JEOL 1230 transmission EM (JEOL USA, Inc).
Western blot analysis
Western blot analysis was performed as we described previously (7, 19) . Protein samples from macrophages were separated by SDS-PAGE, transferred onto the membrane (Millipore), and then incubated with primary antibodies, including anti-LC3, antiphospho-AMPK, anti-AMPK, and anti-GAPDH, and the secondary antibody for 1 hour at room temperature in dark. The bands were detected by Odyssey system (Li-COR). The ratio of the protein interested was subjected to GAPDH and was analyzed by Odyssey software.
NF-B luciferase assay
NF-B transcriptional activity was evaluated using a NF-B luciferase reporter as described (7, 29) . Briefly, the adherents BMDMs were infected with Ad.NF-B-Luc at a multiplicity of infection of 5 for 24 hours before treatment with globular APN (10 g/mL) or Ang II (100nM). The cells were detected for the NF-B activity with luciferase reporter assay system (Promega) according to the manufacturer's instructions. Relative light units of Firefly luciferase activity were normalized with the luciferase activity of the cells with saline treatment.
Statistical analysis
Data were expressed as the mean Ϯ SEM. Differences between groups were performed for statistical significance using Student's t test or ANOVA followed by Newman-Keuls multiple comparison test from GraphPad Prism 5.0. P Ͻ .05 denoted the statistically significant difference.
Results
APN deficiency enhances the severity of Ang IIinduced cardiac fibrosis in mice
To investigate the role of APN in Ang II-induced cardiac injury, we first measured SBP in WT and APN KO mice 7 days after Ang II infusion. The SBP in both APN WT and KO mice was significantly increased after 7 days of Ang II infusion, whereas WT and APN KO mice treated with saline had normal SBP (Supplemental Figure 1) , which is consistent with the previous study that APN KO did not affect BP (11) . Furthermore, there was no change after Ang II infusion, neither APN KO had any effect (Supplemental Figure 1) . Echocardiography was also performed to measure the cardiac function in WT and APN KO mice, and we found that there was no difference between APN KO and WT mice 7 days after Ang II infusion (Supplemental Figure 2) .
To determine whether APN deficiency affects Ang IIinduced cardiac fibrosis, WT and APN KO mice were infused with saline or Ang II for 7 days. The cardiac fibrotic areas were detected by Masson's trichrome staining. As shown in Figure 1A , Ang II infusion significantly increased the heart tissue fibrotic areas in WT mice compared with those infused with saline, and this effect was further enhanced in APN KO mice. Moreover, immunohistochemistry and RT-PCR analysis showed that the levels of collagen I (a major extracellular matrix component) and ␣-SMA (a myofibroblast marker) expression were much higher in APN KO mice than in WT mice after 7 days of Ang II infusion (Figure 1, B-D) . In contrast, the expression levels of collagen I and ␣-SMA were similar in both WT and APN KO hearts after saline infusion (Figure 1, B-D) .
These results suggest that APN deficiency worsens Ang II-induced cardiac fibrosis.
APN deficiency promotes Ang II-induced cardiac inflammation
To assess the effect of APN on Ang II-induced cardiac inflammation, we performed H&E and immunohistochemical staining and found that there were fewer infiltrating and Mac-2-positive cells in saline-treated WT and APN KO mice ( Figure 2 , A and B). Conversely, Ang II infusion significantly increased the infiltration of inflammatory cells and Mac-2-positive macrophages in the hearts of WT littermates compared with saline-treated WT mice, and the number of cells that infiltrated the cardiac tissue was markedly enhanced in APN KO mice after Ang II infusion ( Figure 2, A and B) . The protein levels of IL-1␤ and TNF-␣ were further determined by using an ELISA kit. As is shown in Figure 2F , IL-1␤ and TNF-␣ were increased in the Ang IItreated APN KO mice.
To further examine the role of APN in the regulation of cardiac inflammation, we conducted immunohistochemical staining and RT-PCR analysis. As shown in Figure 2 , C-E, IL-1␤ and TNF-␣ expression were markedly increased in the hearts of APN KO mice relative to WT mice, whereas obvious expression of these cytokines was not detected in WT or APN KO mice after saline infusion. These results suggest that knockout of APN can enhance cardiac inflammation in response to Ang II. Moreover, flow cytometry of WT or APN KO mice hearts was performed after saline or Ang II infusion to further demonstrate the infiltrated macrophages. As is shown in Figure  3 , fluorescence-activated cell sorter analysis showed that Ang II infusion significantly increased the infiltration of CD45 ϩ , F4/80 ϩ , CD206 ϩ cells into heart, whereas APN deficiency led to up-regulation of M2 macrophage markers (F4/80 ϩ CD206 ϩ ) in hearts after Ang II infusion, compared with WT mice.
APN administration inhibits NF-B-mediated inflammation in macrophages
Because NF-B is thought to play an important role in the onset of inflammation and development of tissue fibrosis (30), we examined the effect of APN on NF-B activity in macrophages using a luciferase reporter assay. As shown in Figure 4A , Ang II treatment significantly increased NF-B luciferase activity in macrophages, whereas treatment with globular APN markedly attenuated this effect. Global APN alone had no effect. Furthermore, Ang II treatment markedly downregulated the expression of antiinflammatory cytokines, including IL-10, Mgl-2, Fizzl, and Arg-1, whereas pretreatment with globular APN had an opposite effect. Interestingly, these Ang II-induced alterations were attenuated by globular APN ( Figure 4B ). These results indicate that increased APN activity can inhibit NF-B-mediated inflammation in macrophages.
To confirm that APN modulates the inflammatory response through the autophagic pathway, we treated Atg5 ϩ/Ϫ macrophages with globular APN and performed RT-PCR analysis to detect antiinflammatory cytokine mRNA expression. As shown in Figure 3C , treatment with globular APN markedly down-regulated the mRNA levels of IL-10, Mgl-2, Fizzl, and Arg-1 in Atg5-deficient macrophages, indicating that APN stimulates autophagy induction, leading to increased expression of antiinflammatory cytokines.
Effect of APN on Ang II-induced macrophage autophagy
Because Ang II induces autophagy in several cell types (31, 32), we next investigated whether APN affects Ang II-induced cardiac autophagy. Immunohistochemistry with anti-LC3 showed that the expression of LC3 protein, an autophagosome marker (12) , in the cardiac tissue of APN KO mice was lower than that in WT mice after Ang II infusion ( Figure 5A ). To determine whether Ang II-induced autophagy occurs in macrophages, we performed immunostaining in heart sections from WT and APN KO using antibodies against LC3 and F4/80 (a macrophage maker). As shown in Figure 5B and TNF-␣ relative to that of GAPDH (bottom). F, Histogram shows the protein expression of IL-1␤ and TNF-␣ in WT and APN KO heart tissues that were detected by ELISA. Data represent the mean Ϯ SEM (n ϭ 6 -8 per group). *, P Ͻ .05; ***, P Ͻ .001 vs saline-treated WT mice; †, P Ͻ .05; † † †, P Ͻ .001 vs Ang II-treated WT mice.
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Qi et al APN Activates Macrophage Autophagy Endocrinology, June 2014, 155(6):2254 -2265 tophagosomes were observed in the saline-infused WT and APN KO mice. Macrophage apoptosis was also detected by costaining of TUNEL and F4/80. As shown in Figure 5C , compared with WT mice, APN KO mice exhibited increase in macrophage cell death after Ang II infusion. Because mitochondrial-generated ROS triggers cell autophagy, we further explored the effect of APN in ROS generation in macrophage mitochondria. We pretreated primary mouse macrophages with globular APN in the presence or absence of Ang II, then performed immunofluorescence analysis and observed that MitoTracker colocalized with DCF in Ang II-treated macrophages, whereas globular APN treatment decreased this effect ( Figure 5D ). To further confirm that APN could enhance macrophage autophagy, we detected the autophagy marker LC3 using immunocytochemistry. Ang II or globular APN stimulated expression of LC3 in macrophages, and the combination of globular APN and Ang II further enhanced LC3 expression ( Figure 5E ). Transmission EM also demonstrated that macrophages treated with globular APN or Ang II had substantially more autophagic vacuoles compared with control cells ( Figure 5F ).
APN regulates macrophage autophagy through the AMPK pathway
AMPK is downstream of APN and plays a critical role in autophagy induction. To determine how APN modulates autophagy, we conducted in vitro experiments using primary mouse macrophages and examined the effect of APN and Compound C, an inhibitor of AMPK, on AMPK phosphorylation (p-AMPK) and LC3 expression ( Figure 6 , A and B). As shown in Figure 6A , Ang II treatment suppressed activation of AMPK. However, APN significantly increased p-AMPK (shown in Figure  6A ) and LC3 (shown in Figure 6B ) expression (both lanes 2 and 4 vs 1), and the combination of APN and Ang II further enhanced these effects, whereas such activation was abrogated by Compound C (shown in Figure 6 , A and B) (lane 3 vs 2 and lane 6 vs 5). These results suggest that APN induces autophagy in macrophages via the AMPK pathway.
Discussion
APN has been recognized as an antidiabetic, antiatherosclerotic, and antiinflammatory protein derived from adipocytes (33) . However, the precise mechanism by which APN regulates the extent of cardiac fibrosis has not been fully clarified. Our results demonstrate that APN deficiency caused severe cardiac fibrosis and inflammation but attenuated autophagy induction in response to Ang II infusion. Treatment of macrophages with APN inhibited the activity of NF-B and up-regulated antiinflammatory cytokine expression. Importantly, APN enhanced the expression of the autophagosome marker LC3 through activation of AMPK in macrophages. Thus, endogenous APN exerts a protective effect on cardiac inflammation and fibrosis in Ang II-induced hypertension.
APN is abundantly expressed in adipocytes and plays important roles in the development of obesity, diabetes, and cardiovascular diseases (9), and study has shown that APN is not expressed in macrophages (34) . Several epidemiological studies demonstrate that circulating APN levels are inversely correlated with cardiovascular disease, for example, plasma APN concentrations are lower in patients with coronary artery disease (35, 36) . In contrast, high plasma APN levels are associated with a lower risk of MI, type 2 diabetes, and atherosclerosis (35, 37, 38) . In addition, APN levels are also reported to rapidly decline after acute MI, type 2 diabetes, hyperlipidemia, and hypertension development (39) . Moreover, APN replenishment ameliorates obesity-related hypertension and reduces atherosclerosis in Apolipoprotein E knockout mice (38, 40) . Importantly, APN deficiency results in severe cardiac fibrosis and left ventricular dysfunction, whereas APN overexpression improves these phenotypes (11) . Consistent with these findings, our present study showed that APN protected Ang II-induced cardiac fibrosis. It is known that APN is primarily produced by sc fat, and there are also reports that APN is expressed in human epicardial adipose tissue, for example, Iacobellis et al (41) have reported that the level of APN expression in epicardial fat is negatively associated with coronary artery disease. Thus, APN may be a protective factor in the development of cardiac fibrosis induced by Ang II. However, the underlying mechanisms remain to be elucidated. Inflammation plays an important role in the initiation and development of cardiac fibrosis (42) . Both macrophages and T cells release cytokines, such as IL-1␤, TNF-␣, interferon-␥, and TGF-␤, which can act on and promote the metabolism and proliferation of cardiac fibroblasts and myocytes (43) . However, the molecular mechanisms that regulate the activation of these cells are not fully understood. In the present study, APN KO increased Ang II-induced inflammation in heart compared with the WT group, but there was no difference observed when not infused by Ang II in neither WT nor APN KO mice (Figures 2 and 3) . We have previously shown that Ang IIinduced inflammation in vivo is pressure dependent, because the pressure is required for activation of platelet and inflammation (22, 23) . Under normal condition, there is no activation of platelet and inflammation; therefore, lack of APN itself does not initiate inflammatory response. Moreover, Fujita et al (11) also showed that there were no differences observed between WT and KO mice when not challenged with Ang II.
We and others have shown that Ang II stimulates NF-B activity and induces proinflammatory cytokine expression (44 -46) . In this study, we showed that Ang II stimulates ROS production, NF-B activation, and pro- Figure 4 . APN inhibits inflammation in macrophages through autophagic pathway. A, Primary mouse macrophages isolated from WT mice were transfected with NF-B luciferase reporter and then treated with globular APN (g-APN, 10 g/mL) in the presence or absence of Ang II (100nM) for 24 hours. NF-B activity was determined by luciferase assay. B, Primary mouse macrophages isolated from WT mice are treated with or without APN (10 g/mL) in the presence or absence of Ang II (100nM) for 24 hours. The mRNA levels of antiinflammatory cytokines, including IL-10, Mgl-2, Fizzl, and Arg-1, were detected by RT-PCR analysis. C, Primary mouse macrophages isolated from Atg5-deficient mice were treated with globular APN (10 g/mL) in the presence or absence of Ang II for 24 hours. The mRNA levels of antiinflammatory cytokines were detected as in B. Data represent the mean Ϯ SEM (n ϭ 4 -6 per group). ##, P Ͻ .01; ###, P Ͻ .001 vs untreated control cells; *, P Ͻ .05; **, P Ͻ .01 vs untreated control cells; †, P Ͻ .05; † †, P Ͻ .01 vs Ang II-treated cells. NS, no significance.
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inflammatory cytokines expression (Figures 4 and 5) . APN by stimulating mitophagy prevents mitochondria production of ROS and suppresses NF-B activation. On the other hand, regulation of expression of IL-4, IL-10, or TGF-␤ is complexed and is controlled by several transcription factors and regulators, including nuclear factor of activated T cells, nuclear factor for interleukin-6 expression, and early growth response gene-1 (47, 48) . Even though NF-B is also involved in regulation of antiinflammatory cytokines, but unlike its role in regulating proinflammatory cytokines, which is primarily regulated by p65/ p50 heterodimer of NF-B, in vitro study indicated that the proximal NF-B binding site in IL-10 promoter is regulated predominantly by p50/50 homodimers that activate IL-10 transcription in macrophages. Moreover, p50/50 homodimers-activated IL-10 transcription requires the transcriptional coactivator cAMP-response element binding protein-binding protein (49) . Indeed, the p50/p50 homodimers of NF-B even inhibit transcription of NF-B-dependent proinflammatory genes (49) . Moreover, expression of antiinflammatory cytokine IL-10 in Th1 cells is regulated by signal transducers and activators of transcription (STAT) 4 and STAT1 pathways (50) . In Th2 cells, IL-10 expression is induced by IL-4-STAT6 through GATA3 and nuclear factor interleukin 3 regulated (NFIL3) (51, 52) . In Th17 cells, IL-10 expression is induced by IL-6/TGF-␤-STAT3 through v-maf musculoaponeurotic fibrosarcoma oncogene (c-Maf) (53) . In Th1 cells, IL-10 is induced by IL-27 through induction of c-Maf (53, 54) . Therefore, activation of antiinflammatory genes is not directly regulated by classic NF-B, which could be a reason for lack of inhibitory effect of APN. Accumulating evidence indicates that APN exhibits antiinflammatory effects in various cells and tissues, for example, APN can inhibit NF-B activation, thereby effectively reducing TNF-␣-stimulated expression of adhesion molecules and the antiinflammatory cytokine IL-8 in endothelial cells (55, 56) , decreasing TNF-␣ production in human macrophages (57) , and increasing the expression of the antiinflammatory cytokine IL-10 and the tissue inhibitor of met- alloproteinase-1 in macrophages (58) . Moreover, APNdeficient mice develop larger infarcts that are associated with increased myocardial cell apoptosis and TNF-␣ expression. In contrast, adenovirus-mediated delivery of APN restores these effects in APN KO mice (39) . The protective action of APN against myocardial ischemia-reperfusion injury appears to be mediated by activation of cyclooxygenase-2 and inhibition of TNF-␣ production in cardiac cells (39) . Moreover, treatment with globular APN inhibits Ang II-induced NF-B activation in neonatal rat ventricular myocytes through AMPK (59) . In the present study, our findings demonstrated that APN deficiency markedly increased Ang II-induced macrophage infiltration and expression of TNF-␣ and IL-1␤ in cardiac tissue (Figure 2 ), whereas treatment of macrophages with globular APN significantly inhibited NF-B activity and upregulated the expression of antiinflammatory cytokines ( Figure 4 ). Thus, APN may act as a key regulator in macrophage activation and the inflammatory response. Autophagy is a lysosome degradation pathway that is critical for maintaining cellular homeostasis under stressful conditions (12) . Abnormal autophagy causes accumulation of dead cell components, which activate macrophages and T cells to produce proinflammatory cytokines (60) . Although autophagy activation is detected in various cardiovascular diseases, including hypertrophy, myocardial injury, and atherosclerosis (12), the responsible mechanisms are not fully understood. We showed in this study that APN increased antiinflammatory cytokines expression ( Figure 4 , B and C) in an autophagy-dependent fashion. This is consistent with the previous report of that APN has antiinflammatory actions. Takemura et al (61) have shown that APN could facilitate the uptake of early apoptotic cells by macrophages. APN is capable of opsonizing apoptotic cells, and phagocytosis of cell corpses is mediated by the binding of APN to calreticulin on the macrophage cell surface. Voll et al (62) reported that uptake of apoptotic cells by macrophages increases their secretion of the antiinflammatory IL-10. The mammalian target of rapamycin signaling pathway negatively regulates autophagy, whereas AMPK activation leads to mTOR inhibition, thereby promoting autophagy. AMPK is an important kinase downstream of the APN pathway and activated by APN via APN receptor. However, little is known about the role of APN in regulating macrophage autophagy. A striking finding of the present study was that APN deficiency ameliorated Ang II-induced macrophage autophagy characterized by increased expression of LC3, an autophagosome marker, whereas treatment of macrophages with APN enhanced the phosphorylation of AMPK and expression of LC3 protein, which was abolished by Compound C (Figure 6 ). Our recent study has showed that Atg5 ϩ/Ϫ deficiency aggravates cardiac inflammation and injury via decreasing macrophage mitophagy in response to Ang II (63) . Moreover, Atg5 deficiency attenuated APN-mediated antiinflammatory cytokine expression (Figure 4 ). Taken together, these results indicate that APN stimulates macrophage autophagy through activation of the AMPK signaling pathway. The effect of APN on macrophage autophagy that we observed could be mediated by both type APN receptors, preferentially type I receptor. Tian et al (64) showed that both Adiponectin receptor 1 (AdipoR1) and AdipoR2 were found to have differential effects in diminishing proinflammatory responses. Although AdipoR1 was required by APN to suppress TNF-␣ and monocyte chemotactic protein 1 gene expression, AdipoR2 served as the dominant receptor for APN suppression of scavenger receptor A type 1 and up-regulation of IL-1 receptor antagonist (64) . In another study, Mandal et al (65) reported that full-length APN, acting via the AdipoR2 receptor, potently shifted the polarization of Kupffer cells and RAW264.7 macrophages to an M2 phenotype, which was also partially dependent on AMPK. However, our present study does not allow us to determine which types of APN receptor are involved in APN-induced autophagy in mac- rophage; therefore, future study is required to identify the type of receptor that mediates the effect. In addition to our observed APN effect on macrophage, there are several reports that demonstrate that APN also has direct effect on fibroblasts. Nakasone et al (66) showed that APN stimulated synthesis of extracellular matrix in dermal fibroblasts. Defects in APN action have been implicated in the development of cardiac dysfunction in obesity and diabetes. Specifically, in cardiac fibroblast, APN stimulated membrane type 1 matrix metalloproteinases translocation, matrix metalloproteinases 2 activity and cell migration of cardiac fibroblasts, linking to heart failure associated with obesity and diabetes (67) . Consistent with our finding, Fujita et al (11) showed that increased cardiac fibrosis was observed in Ang II-infused APN KO mice, and they further showed that in cultured cardiac fibroblasts, APN stimulated AMPK activity and suppressed Ang II-induced ERK1/2 activity through AMPK-dependent peroxisome proliferator-activatived receptors-␣ activation. Along with our present study, APN prevents cardiac fibrosis possibly depending on its effects on both macrophages and fibroblasts.
In summary, we demonstrated that APN deficiency enhanced Ang II-induced cardiac inflammation and fibrosis and decreased autophagy activation in cardiac tissue. In contrast, treatment of macrophages with APN markedly increased AMPK activation-mediated autophagy and upregulated antiinflammatory cytokine expression. Our results suggest that APN protects against Ang II-induced cardiac fibrosis at least in part through AMPK-dependent autophagy activation. But one of the limitations of our present study is lack of examination of whether exogenous APN supplementation could prevent the effect of pathological phenotypes in APN KO mice. The results of the present study may provide a novel therapeutic target against heart fibrosis.
